ID4 Antibody: What It Targets, How It Works, and What It Means for Research

What the ID4 Antibody Recognizes

The ID4 antibody is a research reagent that detects the ID4 protein, also known as inhibitor of DNA binding 4. ID4 belongs to the inhibitor of differentiation (ID) family of transcription factors, which function primarily by heterodimerizing with basic helix-loop-helix (bHLH) proteins and preventing them from binding DNA. Unlike typical transcription factors, ID4 lacks a basic DNA-binding domain, so its regulatory role depends entirely on protein-protein interactions. The antibody is raised against a specific epitope within the ID4 sequence and is used in techniques such as Western blotting, immunohistochemistry, immunofluorescence, and flow cytometry to visualize ID4 expression in cells and tissues.

Biological Role of ID4

ID4 is a helix-loop-helix protein that acts as a negative regulator of transcription. By sequestering bHLH partners, it modulates gene programs controlling cell proliferation, differentiation, and lineage commitment. ID4 is most prominently studied in the nervous system, where it influences neural crest cell development and axon guidance. Outside the nervous system, ID4 participates in the regulation of hematopoietic stem cells and vascular smooth muscle cell phenotype switching. Its expression is tightly controlled during development and is often altered in disease states, including cancers where differentiation programs are disrupted.

Applications in Cancer Research

Researchers use the ID4 antibody to examine how ID4 expression changes across tumor types. In some cancers, ID4 acts as a tumor suppressor by blocking differentiation arrest, while in others it supports stem-like properties that drive tumor progression. The antibody enables studies of ID4 protein levels in tumor biopsies and cultured cell lines, helping to clarify whether ID4 is up- or downregulated in a given context. Combining ID4 antibody staining with markers of proliferation and differentiation provides a snapshot of how a tumor's regulatory networks are rewired. Because ID4 interacts with a broad set of bHLH partners, interpreting staining patterns requires careful controls and an understanding of the downstream pathways involved.

Techniques and Experimental Considerations

When using the ID4 antibody, researchers should validate the application for their specific model. Western blotting confirms protein size and expression level, while immunohistochemistry and immunofluorescence reveal spatial distribution in tissue sections or cultured cells. Antibody specificity can be assessed by comparing signal in ID4-expressing versus ID4-knockout or knockdown systems. Because ID4 belongs to a family of related proteins, cross-reactivity with ID1, ID2, or ID3 is a potential concern that depends on the antibody clone and epitope mapping. Titration experiments help determine the optimal concentration that maximizes signal-to-noise ratio for each application.

Choosing the Right ID4 Antibody

Several monoclonal and polyclonal ID4 antibodies are commercially available, each with a different host species, clone, and validated application profile. The choice depends on the intended use: a conjugated antibody may be preferred for flow cytometry, while a high-sensitivity polyclonal preparation can improve detection in low-expressing tissues. Researchers should consult the manufacturer's data on immunogen sequence, application list, and published citations to confirm that the antibody has been tested in their experimental context. Lot-to-lot consistency, storage conditions, and dilution buffers also affect reproducibility.

ID4 Antibody in Mechanistic Studies

Beyond detection, the ID4 antibody supports functional studies when combined with perturbation approaches. Researchers can correlate changes in ID4 protein levels with downstream transcriptional activity using reporter assays or RNA sequencing. Co-immunoprecipitation experiments using the antibody can identify interaction partners in complex lysates, shedding light on which bHLH networks are active in a particular cell state. These approaches help move ID4 from a correlative marker to a mechanistic node in developmental and disease models.